Did GACP purchase $250,000 dollars worth of stock in April?
Perhaps a larger investment has been made since then...
an increase in cash on hand (assets) would be a nice surprise in the Q..
SUNRISE, FL / ACCESSWIRE / April 13, 2017 / U.S. Stem Cell, Inc. (USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal patients, has received a commitment to invest up to $5,000,000 from private equity firm General American Capital Partners LLC (GACP) in exchange for up to 63,873,275 shares of common stock.
News 
Market Data 
Discover 
